ESC 365 - One-year right heart failure outcomes in patients with severe tricuspid regurgitation in the TRISCEND II trial

Open Access

One-year right heart failure outcomes in patients with severe tricuspid regurgitation in the TRISCEND II trial

Session: Interventional cardiology

Topic: Tricuspid Valve Intervention

Speaker: Doctor M. Hell (Mainz, DE)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Michaela Hell

University Medical Centre of the Johannes Gutenberg University, Mainz (Germany)

1 presentation

0 follower

6 more presentations in this session

Improvement of mitral regurgitation following transcatheter aortic valve implantation: outcomes and predictors in a retrospective cohort study

Speaker: Doctor M. Paralta De Figueiredo (Evora, PT)

Preservation dilemma: prognosis across the preserved spectrum of transcatheter aortic valve replacement patients for severe aortic stenosis

Speaker: Doctor T. Pereira dos Santos (Coimbra, PT)

Antithrombotic therapy after valve-in-valve, valve-in-ring and valve-in-MAC: review and metaanalysis

Speaker: Doctor G. Terleira Batista (Coimbra, PT) Doctor M. Rodrigues Simoes (Coimbra, PT)

A single-centre perspective on survival and complications after transcatheter aortic valve replacement in chronic kidney disease and end-stage renal disease patients

Speaker: Doctor T. Pereira dos Santos (Coimbra, PT)

Unlocking recovery: predictors and outcomes of left ventricular dysfunction after TAVI

Speaker: Doctor S. Esteves (Lisbon, PT)

Access the full session

Interventional cardiology

Speakers: Doctor M. Hell, Doctor M. Paralta De Figueiredo, Doctor T. Pereira dos Santos, Doctor G. Terleira Batista, Doctor M. Rodrigues Simoes...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources